SIPA1L2 | | | | 0 | 0 |
SIPA1 | | | | 0 | 0 |
SIN3A | | | | 0 | 0 |
SIMC1 | | | | 0 | 0 |
SIK1 | | | | 0 | 0 |
SI | | | | 0 | 0 |
SHROOM3 | | | | 0 | 0 |
SHQ1 | | | | 0 | 0 |
SHPRH | | | | 0 | 0 |
SHOC2 | | | | 0 | 0 |
SHMT1 | | | | 0 | 0 |
SHH | | | | 0 | 0 |
SHBG | | | | 0 | 0 |
SH3PXD2A | | | | 0 | 0 |
SH2D2A | | | | 0 | 0 |
SH2D1A | | | | 0 | 0 |
SH2B3 | 结直肠癌 | | | 1 | 1 |
SGK1 | 乳腺癌 | 阿培利司,SGK1-Inh, | | 1 | 3 |
SGCZ | | | | 0 | 0 |
SFXN4 | | | | 0 | 0 |
SFPQ | | | | 0 | 0 |
SF3B1 | 乳腺癌,慢性淋巴细胞白血病,骨髓增生异常综合征 | Spliceostatin A, | | 3 | 9 |
SF3A3 | | | | 0 | 0 |
SF3A1 | | | | 0 | 0 |
SF1 | | | | 0 | 0 |
SETMAR | | | | 0 | 0 |
SETDB1 | | | | 0 | 0 |
SETD2 | | | | 0 | 0 |
SETBP1 | 慢性粒细胞白血病,少年粒细胞白血病 | | | 3 | 3 |
SESN3 | | | | 0 | 0 |
SESN2 | | | | 0 | 0 |
SESN1 | | | | 0 | 0 |
SERPINB4 | | | | 0 | 0 |
SERPINB3 | | | | 0 | 0 |
SERPINA7 | | | | 0 | 0 |
SERP2 | | | | 0 | 0 |
Sept9 | | | | 0 | 0 |
Sept14 | | | | 0 | 0 |
SEMA6A | | | | 0 | 0 |
SEMA3E | | | | 0 | 0 |
SEMA3C | | | | 0 | 0 |
SEMA3A | | | | 0 | 0 |
SEL1L3 | | | | 0 | 0 |
SEC31A | | | | 0 | 0 |
SDHD | | | | 0 | 0 |
SDHC | | | | 0 | 0 |
SDHB | 副神经节瘤 | | | 1 | 1 |
SDHAF2 | | | | 0 | 0 |
SDHA | | | | 0 | 0 |
SDCCAG8 | | | | 0 | 0 |
SDC4 | | | | 0 | 0 |
SCUBE2 | | | | 0 | 0 |
SCN8A | 肺腺癌 | 派姆单抗(帕博利珠单抗), | | 1 | 1 |
SCG5 | | | | 0 | 0 |
SBNO2 | | | | 0 | 0 |
SBDS | | | | 0 | 0 |
SATB2 | | | | 0 | 0 |
SASH1 | | | | 0 | 0 |
SAMD9 | | | | 0 | 0 |
SALL1 | | | | 0 | 0 |
RYR3 | | | | 0 | 0 |
RYR2 | | | | 0 | 0 |
RYR1 | | | | 0 | 0 |
RYBP | | | | 0 | 0 |
RXRG | | | | 0 | 0 |
RXRB | | | | 0 | 0 |
RXRA | | | | 0 | 0 |
RUNX3 | | | | 0 | 0 |
RUNX2 | | | | 0 | 0 |
RUNX1T1 | | | | 0 | 0 |
RUNX1 | 急性淋巴细胞性白血病,急性髓性白血病,骨髓增生异常综合征 | | 阿糖胞苷, | 7 | 13 |
RUFY4 | | | | 0 | 0 |
RTEL1 | | | | 0 | 0 |
RSPO3 | | | | 0 | 0 |
RSPO2 | | | | 0 | 0 |
RSF1 | 乳腺癌 | | 他莫昔芬, | 1 | 1 |
RRP1B | | | | 0 | 0 |
RRM2 | 胰腺癌 | | 吉西他滨, | 1 | 1 |
RRM1 | 非小细胞肺癌,胰腺癌 | Cisplatine,PLATINUM, | 顺铂,多西他赛,吉西他滨,吉西他滨,顺铂,紫杉醇,长春瑞滨, | 2 | 9 |
RRAS2 | | | | 0 | 0 |
RRAS | | | | 0 | 0 |
RRAGC | | | | 0 | 0 |
RPTOR | | | | 0 | 0 |
RPS7 | | | | 0 | 0 |
RPS6KB2 | | | | 0 | 0 |
RPS6KB1 | | | | 0 | 0 |
RPS6KA4 | | | | 0 | 0 |
RPS6KA3 | | | | 0 | 0 |
RPS6KA1 | | | | 0 | 0 |
RPS6 | 胃腺癌 | 依维莫司, | | 1 | 1 |
RPS29 | | | | 0 | 0 |
RPS26 | | | | 0 | 0 |
RPS24 | | | | 0 | 0 |
RPS19 | | | | 0 | 0 |
RPS17 | | | | 0 | 0 |
RPS14 | | | | 0 | 0 |
RPS10 | | | | 0 | 0 |
RPP30 | | | | 0 | 0 |
RPL5 | | | | 0 | 0 |
RPL35A | | | | 0 | 0 |
RPL22 | | | | 0 | 0 |
RPL11 | | | | 0 | 0 |
RPGR | | | | 0 | 0 |
RPA4 | | | | 0 | 0 |
RPA1 | | | | 0 | 0 |
RP1L1 | | | | 0 | 0 |
ROS1 | 支气管肺泡腺癌,癌,大肠癌,多形胶质母细胞瘤,炎性肌成纤维细胞瘤,肺腺癌,非小细胞肺癌 | AZD3463,布加替尼,卡博替尼,色瑞替尼,塞瑞替尼,克唑替尼,恩曲替尼,Foretinib,吉非替尼,劳拉替尼,TAE684, | | 12 | 31 |
ROCK2 | | | | 0 | 0 |
ROCK1 | | | | 0 | 0 |
ROBO4 | 癌症 | Antiangiogenic Therapy, | | 1 | 1 |
ROBO3 | | | | 0 | 0 |
ROBO2 | | | | 0 | 0 |
ROBO1 | | | | 0 | 0 |
RNF43 | | | | 0 | 0 |
RNF213 | | | | 0 | 0 |
RNF19A | | | | 0 | 0 |
RNASEL | | | | 0 | 0 |
RMI2 | | | | 0 | 0 |
RIT1 | 子宫内膜癌,肺腺癌 | Pictilisib,司美替尼, | | 2 | 2 |
RIPK4 | | | | 0 | 0 |
RIPK2 | | | | 0 | 0 |
RINT1 | | | | 0 | 0 |
RICTOR | 胃腺癌,肺腺癌,小细胞肺癌 | AZD2014,AZD8055,CC-223,INK128,Sapanisertib, | | 1 | 3 |
RIC1 | | | | 0 | 0 |
RHPN1 | | | | 0 | 0 |
RHOT1 | | | | 0 | 0 |
RHOH | | | | 0 | 0 |
RHOA | 胃癌 | | | 1 | 1 |
RHEB | 肾癌 | 西罗莫司, | | 1 | 1 |
RHBDF2 | | | | 0 | 0 |
RGS3 | | | | 0 | 0 |
RGPD3 | | | | 0 | 0 |
RFC4 | | | | 0 | 0 |
RFC1 | | | | 0 | 0 |
REV3L | | | | 0 | 0 |
REV1 | | | | 0 | 0 |
RET | 乳腺癌,癌症,雌激素受体阴性乳腺癌,胃肠道间质瘤,肺腺癌,肺癌,非小细胞肺癌,乳头状腺癌,乳头状甲状腺癌,甲状腺癌,甲状腺髓样癌 | 阿来替尼,艾乐替尼,阿昔替尼,AZD1480,卡博替尼,依维莫司,INK128,仑伐替尼 乐伐替尼,塞尔帕替尼,尼达尼布,NVP-AST487,帕纳替尼/普纳替尼/波纳替尼,瑞戈非尼,索拉非尼,舒尼替尼,凡德他尼, | 莫特塞尼, | 13 | 36 |
RELN | | | | 0 | 0 |
RELA | | | | 0 | 0 |
REL | 弥漫性大B细胞淋巴瘤 | | | 1 | 1 |
REG3A | | | | 0 | 0 |
REEP5 | | | | 0 | 0 |
RECQL4 | | | | 0 | 0 |
RECQL | | | | 0 | 0 |
RBM27 | | | | 0 | 0 |
RBM10 | | | | 0 | 0 |
RBL1 | | | | 0 | 0 |
RBI | | | | 0 | 0 |
RBBP8 | | | | 0 | 0 |
RB1 | 乳腺癌,雌激素受体阳性乳腺癌,多形胶质母细胞瘤,非小细胞肺癌,小细胞肺癌,胰腺腺癌,膀胱癌 | 阿培利司,Chemotherapy,丝裂霉素C,哌柏西利,帕博西尼,帕博西林,瑞博西尼, | 氟尿嘧啶,多柔比星,吉西他滨, | 7 | 9 |
RASSF8 | | | | 0 | 0 |
RASSF1 | | | | 0 | 0 |
RASGRP1 | | | | 0 | 0 |
RASGEF1A | | | | 0 | 0 |
RASA1 | 非小细胞肺癌 | 曲美替尼, | | 1 | 1 |
RARG | | | | 0 | 0 |
RARB | | | | 0 | 0 |
RARA | | | | 0 | 0 |
RANBP2 | | | | 0 | 0 |
RAI14 | | | | 0 | 0 |
RAF1 | 黑色素瘤,皮肤黑色素瘤 | 索拉非尼,维莫非尼, | 卡铂,紫杉醇, | 2 | 2 |
RAD54L | | | | 0 | 0 |
RAD54B | | | | 0 | 0 |
RAD52 | | | | 0 | 0 |
RAD51D | 乳腺癌 | | | 1 | 1 |
RAD51C | | | | 0 | 0 |
RAD51B | | | | 0 | 0 |
RAD51 | | | | 0 | 0 |
RAD50 | 输尿管小细胞癌 | AZD7762, | 伊立替康, | 1 | 1 |
RAD23B | 肉瘤 | 伏立诺他, | | 1 | 1 |
RAD21 | | | | 0 | 0 |
RAC3 | | | | 0 | 0 |
RAC2 | | | | 0 | 0 |
RAC1 | 黑色素瘤 | 达拉非尼,维莫非尼, | | 1 | 1 |
RABGAP1L | | | | 0 | 0 |
RAB35 | | | | 0 | 0 |
QKI | | | | 0 | 0 |
PXDNL | 肺腺癌 | 派姆单抗(帕博利珠单抗), | | 1 | 1 |
PURA | | | | 0 | 0 |
PTTG1 | 脑膜瘤 | | | 1 | 1 |
PTPRZ1 | | | | 0 | 0 |
PTPRU | | | | 0 | 0 |
PTPRT | 头颈部鳞状细胞癌 | JSI-124,Stattic, | | 1 | 1 |
PTPRS | | | | 0 | 0 |
PTPRO | | | | 0 | 0 |
PTPRK | | | | 0 | 0 |
PTPRJ | | | | 0 | 0 |
PTPRF | 非小细胞肺癌 | Erlotinib Hydrochloride, | | 1 | 2 |
PTPRD | 骨尤文氏肉瘤,头颈癌 | 西妥木单抗,JSI-124,R1507, | | 2 | 2 |
PTPRB | 血管肉瘤 | 舒尼替尼, | | 1 | 1 |
PTPN6 | 肝细胞癌 | | | 1 | 1 |
PTPN22 | | | | 0 | 0 |
PTPN2 | | | | 0 | 0 |
PTPN13 | | | | 0 | 0 |
PTPN12 | 三受体阴性乳腺癌 | 克唑替尼,舒尼替尼, | | 1 | 1 |
PTPN11 | 少年骨髓单核细胞白血病,喉癌,毛细胞星形细胞瘤 | | | 3 | 3 |
PTP4A3 | 结直肠癌 | 西妥昔单抗, | | 1 | 1 |
PTP4A1 | | | | 0 | 0 |
PTK6 | | | | 0 | 0 |
PTK2B | 小儿B细胞急性淋巴细胞白血病 | | | 2 | 2 |
PTK2 | | | | 0 | 0 |
PTGS2 | 结直肠癌 | 阿司匹林, | | 1 | 1 |
PTGS1 | | | | 0 | 0 |
PTGIS | | | | 0 | 0 |
PTEN | 膀胱癌,乳腺癌,癌症,结直肠癌,子宫内膜癌,子宫内膜增生,胃腺癌,多形胶质母细胞瘤,头颈癌,头颈鳞状细胞癌,Her2受体阳性乳腺癌,黑色素瘤,卵巢癌,胰腺癌,前列腺癌腺癌,前列腺癌,pten错构瘤肿瘤综合征,皮肤黑色素瘤,实体瘤,胃癌,甲状腺癌 | Tanespimycin,Capivasertib,AZD8186,Buparlisib,阿培利司,西妥昔单抗,Chemotherapy,达可替尼,EGFR Inhibitor,恩扎鲁胺,厄洛替尼,依维莫司,氟维司群,吉非替尼,Uprosertib,Ipatasertib,拉帕替尼,LY294002,MK-2206,MTOR Inhibitors,帕尼单抗,PD184352,Perifosine,Pictilisib,Torkinib,Ridaforolimus,Taselisib,西罗莫司,曲妥珠单抗,维莫非尼, | 卡铂,顺铂,多西他赛,紫杉醇, | 8 | 53 |
PTCH2 | | | | 0 | 0 |
PTCH1 | 基底细胞癌,脑髓母细胞瘤,癌,髓母细胞瘤 | 索尼德吉,维莫德吉, | | 7 | 8 |
PSMD4 | 乳腺癌,结直肠癌 | 卡非佐米,他拉唑帕尼, | | 2 | 2 |
PSMB8 | 胃腺癌 | | | 1 | 1 |
PSMB5 | | | | 0 | 0 |
PSMB2 | | | | 0 | 0 |
PSMB1 | | | | 0 | 0 |
PSIP1 | | | | 0 | 0 |
PSG2 | | | | 0 | 0 |
PRX | | | | 0 | 0 |
PRSS8 | | | | 0 | 0 |
PRSS3 | | | | 0 | 0 |
PRSS1 | | | | 0 | 0 |
PRRX1 | | | | 0 | 0 |
PRRT2 | | | | 0 | 0 |
PRPF40B | | | | 0 | 0 |
PRPF39 | | | | 0 | 0 |
PROM1 | 肝细胞癌 | 索拉非尼, | | 1 | 1 |
PROKR2 | | | | 0 | 0 |
PRKN | | | | 0 | 0 |
PRKDC | | | | 0 | 0 |
PRKD1 | | | | 0 | 0 |
PRKCI | | | | 0 | 0 |
PRKCG | | | | 0 | 0 |
PRKCE | | | | 0 | 0 |
PRKCB | 成人T细胞白血病 | | | 1 | 1 |
PRKCA | | | | 0 | 0 |
PRKAR1A | | | | 0 | 0 |
PRKACG | | | | 0 | 0 |
PRKACB | | | | 0 | 0 |
PRKACA | 肝细胞纤维板层癌,肝细胞混合纤维板层癌 | | | 1 | 4 |
PRKAA2 | 癌症 | ACLY SiRNA, | | 1 | 1 |
PRKAA1 | | | | 0 | 0 |
PRIM2 | | | | 0 | 0 |
PRF1 | | | | 0 | 0 |
PREX2 | 黑色素瘤 | 维莫非尼, | | 1 | 1 |
PRDM16 | | | | 0 | 0 |
PRDM14 | | | | 0 | 0 |
PRDM1 | 弥漫性大B细胞淋巴瘤 | | | 1 | 2 |
PRCC | | | | 0 | 0 |
PRAM1 | | | | 0 | 0 |
PPP6C | | | | 0 | 0 |
PPP4R2 | | | | 0 | 0 |
PPP2R5B | | | | 0 | 0 |
PPP2R2A | | | | 0 | 0 |
PPP2R1A | | | | 0 | 0 |
PPP1R17 | | | | 0 | 0 |
PPP1R15A | 结直肠癌 | 贝伐单抗,FOLFIRI Regimen, | | 1 | 1 |
PPM1D | | | | 0 | 0 |
PPHLN1 | | | | 0 | 0 |
PPARG | | | | 0 | 0 |
PPARD | | | | 0 | 0 |
POU5F1 | 结肠癌 | | 奥沙利铂, | 1 | 1 |
POU2AF1 | | | | 0 | 0 |
POTEG | | | | 0 | 0 |
POT1 | 慢性淋巴细胞白血病 | | | 1 | 1 |
POM121L12 | | | | 0 | 0 |
POM121 | | | | 0 | 0 |
POLR2B | | | | 0 | 0 |
POLQ | | | | 0 | 0 |
POLN | | | | 0 | 0 |
POLM | | | | 0 | 0 |
POLH | | | | 0 | 0 |
POLG | | | | 0 | 0 |
POLE4 | 肺腺癌 | 派姆单抗(帕博利珠单抗), | | 1 | 1 |
POLE | 结直肠癌,子宫内膜癌,多形性胶质母细胞瘤 | 派姆单抗(帕博利珠单抗), | | 4 | 5 |
POLDIP2 | | | | 0 | 0 |
POLD3 | | | | 0 | 0 |
POLD1 | 肺腺癌,非小细胞肺癌 | 派姆单抗(帕博利珠单抗), | | 3 | 3 |
PNRC1 | | | | 0 | 0 |
PNPLA3 | | | | 0 | 0 |
PNO1 | | | | 0 | 0 |
PMS2 | 多形性胶质母细胞瘤,林奇综合征 | 纳武单抗(纳武利尤单抗), | | 2 | 2 |
PMS1 | | | | 0 | 0 |
PML | 急性早幼粒细胞白血病 | All-trans Retinoic Acid, | 三氧化二砷, | 4 | 7 |
PMAIP1 | | | | 0 | 0 |
PLXNB2 | | | | 0 | 0 |
PLXNA1 | | | | 0 | 0 |
PLPPR4 | | | | 0 | 0 |
PLK2 | | | | 0 | 0 |
PLK1 | | | | 0 | 0 |
PLEKHH2 | | | | 0 | 0 |
PLEKHA1 | | | | 0 | 0 |
PLCG2 | 慢性淋巴细胞白血病 | | | 1 | 1 |
PLCG1 | | | | 0 | 0 |
PLCB1 | | | | 0 | 0 |
PLAG1 | | | | 0 | 0 |
PLAC8 | | | | 0 | 0 |
PLA2G1B | | | | 0 | 0 |
PKHD1 | | | | 0 | 0 |
PKD2 | | | | 0 | 0 |
PKD1L2 | | | | 0 | 0 |
PIP5K1A | | | | 0 | 0 |
PIM1 | 非小细胞肺癌 | | | 1 | 1 |
PIK3R3 | | | | 0 | 0 |
PIK3R2 | 黑色素瘤 | 维莫非尼, | | 2 | 2 |
PIK3R1 | 乳腺癌,多形性胶质母细胞瘤 | Buparlisib,Torkinib, | | 1 | 2 |
PIK3CG | | | | 0 | 0 |
PIK3CD | | | | 0 | 0 |
PIK3CB | | | | 0 | 0 |
PIK3CA | 乳腺癌,癌症,宫颈癌,结直肠癌,子宫内膜癌,上皮性卵巢癌,雌激素受体阳性乳腺癌,胃腺癌,多形性胶质母细胞瘤,头颈癌,头颈鳞状细胞癌,HER2受体阳性乳腺癌,侵袭性管状乳腺癌,lunG腺癌,非小细胞肺癌,黑色素瘤,默克尔细胞癌,胃癌,甲状腺癌 | Tanespimycin,Ado-trastuzumab,阿法替尼,阿培利司,Anti-EGFR Monoclonal Antibody,Apitolisib,阿司匹林,Capivasertib,贝伐单抗,Dactolisib,Buparlisib,卡博替尼,Celecoxib,西妥昔单抗,CH5132799,厄洛替尼,依维莫司,氟维司群,吉非替尼,布洛芬,艾代拉里斯,拉帕替尼,MK-2206,Dactolisib,哌柏西利,帕博西尼,帕博西林,帕尼单抗,Perifosine,PI103,PI3K Inhibitor,Pictilisib,Torkinib,Radiation,西罗莫司,瑞戈非尼,瑞博西尼,Ridaforolimus,Taselisib,曲美替尼,曲妥珠单抗,维莫非尼, | 氟尿嘧啶,顺铂,环磷酰胺,多柔比星,表柔比星,伊立替康,奥沙利铂,紫杉醇,舒林酸,他莫昔芬, | 40 | 265 |
PIK3C3 | | | | 0 | 0 |
PIK3C2G | | | | 0 | 0 |
PIK3C2B | | | | 0 | 0 |
PIK3C2A | | | | 0 | 0 |
PIGF | | | | 0 | 0 |
PIBF1 | | | | 0 | 0 |
PHOX2B | | | | 0 | 0 |
PHLPP2 | | | | 0 | 0 |
PHF7 | | | | 0 | 0 |
PHF6 | | | | 0 | 0 |
PHF20L1 | | | | 0 | 0 |
PHF1 | | | | 0 | 0 |
PH0X2B | | | | 0 | 0 |
PGR | 乳腺癌 | 依西美坦, | 他莫昔芬, | 1 | 4 |
PGBD1 | | | | 0 | 0 |
PER1 | | | | 0 | 0 |
PEG3 | | | | 0 | 0 |
PDZRN3 | | | | 0 | 0 |
PDYN | | | | 0 | 0 |
PDPN | | | | 0 | 0 |
PDPK1 | | | | 0 | 0 |
PDK1 | | | | 0 | 0 |
PDILT | | | | 0 | 0 |
PDHA2 | | | | 0 | 0 |
PDGFRB | 急性淋巴细胞白血病,成人B淋巴细胞白血病,慢性骨髓单核细胞白血病,慢性骨髓增生性疾病,血液学癌症,小儿B细胞急性淋巴细胞白血病,小儿B细胞淋巴细胞白血病 | 巴非替尼,CHZ868,达沙替尼,伊马替尼,尼洛替尼,帕纳替尼/普纳替尼/波纳替尼,Rebastinib, | | 4 | 11 |
PDGFRA | 癌症,慢性骨髓单核细胞白血病,胃肠道间质瘤,非小细胞肺癌,黑色素瘤,骨髓和淋巴肿瘤伴嗜酸性粒细胞增多和pdgfra,pdgfrb和fgfr1异常 | Crenolanib,达沙替尼,伊马替尼,Imatinib Mesylate,帕纳替尼/普纳替尼/波纳替尼,舒尼替尼, | | 21 | 45 |
PDGFB | 小儿B淋巴细胞白血病 | 达沙替尼,伊马替尼, | | 1 | 1 |
PDE6C | | | | 0 | 0 |
PDE4DIP | | | | 0 | 0 |
PDE4D | | | | 0 | 0 |
PDE3A | | | | 0 | 0 |
PDE1C | | | | 0 | 0 |
PDE11A | | | | 0 | 0 |
PDCD4 | 肺癌 | | 紫杉醇, | 1 | 1 |
PDCD1LG2 | 头颈癌 | 派姆单抗(帕博利珠单抗), | | 1 | 1 |
PDCD11 | | | | 0 | 0 |
PDCD1 | | | | 0 | 0 |
PCSK7 | | | | 0 | 0 |
PCSK6 | | | | 0 | 0 |
PCLO | | | | 0 | 0 |
PCK1 | | | | 0 | 0 |
PCDH9 | | | | 0 | 0 |
PCDH18 | | | | 0 | 0 |
PCDH17 | | | | 0 | 0 |
PCDH10 | | | | 0 | 0 |
PCBP1 | | | | 0 | 0 |
PC | | | | 0 | 0 |
PBX1 | | | | 0 | 0 |
PBRM1 | 透明细胞肾细胞癌,肾细胞癌 | 阿特朱单抗,阿替利珠单抗,阿维单抗 巴文西亚,度伐利尤单抗,德瓦鲁单抗,CTLA-4 Inhibitor,依维莫司,伊匹单抗,PD-L1 Antibody,派姆单抗(帕博利珠单抗),纳武单抗(纳武利尤单抗), | | 2 | 5 |
PBLD | 肝细胞癌 | | | 1 | 1 |
PBK | 胃腺癌,非小细胞肺癌 | 吉非替尼, | | 2 | 2 |
PAX8 | 女性生殖器官癌 | | | 2 | 2 |
PAX7 | | | | 0 | 0 |
PAX5 | 小儿B淋巴细胞白血病 | | | 1 | 2 |
PAX3 | | | | 0 | 0 |
PASK | | | | 0 | 0 |
PARP4 | | | | 0 | 0 |
PARP3 | | | | 0 | 0 |
PARP2 | | | | 0 | 0 |
PARP1 | 周围神经鞘恶性肿瘤 | 奥拉帕利, | | 1 | 1 |
PARK2 | | | | 0 | 0 |
PAQR8 | | | | 0 | 0 |
PAPPA2 | 肺腺癌 | 派姆单抗(帕博利珠单抗), | | 1 | 1 |
PAPOLG | | | | 0 | 0 |
PALLD | | | | 0 | 0 |
PALB2 | 乳腺癌,胰腺癌,前列腺癌 | 丝裂霉素C,奥拉帕利, | | 2 | 3 |
Pak7 | | | | 0 | 0 |
PAK6 | | | | 0 | 0 |
PAK5 | | | | 0 | 0 |
PAK3 | | | | 0 | 0 |
PAK1 | | | | 0 | 0 |
PAG1 | | | | 0 | 0 |
PABPC3 | | | | 0 | 0 |
PABPC1 | | | | 0 | 0 |
P4HB | | | | 0 | 0 |
P2RY8 | | | | 0 | 0 |
OTOS | | | | 0 | 0 |
OSBPL9 | | | | 0 | 0 |
OR6F1 | | | | 0 | 0 |
OR5L2 | | | | 0 | 0 |
OR4C6 | | | | 0 | 0 |
OR4A15 | | | | 0 | 0 |
OR2T4 | | | | 0 | 0 |
OR11G2 | | | | 0 | 0 |
OPRM1 | | | | 0 | 0 |
OPCML | | | | 0 | 0 |
OMD | | | | 0 | 0 |
OGDH | | | | 0 | 0 |
OBSL1 | | | | 0 | 0 |
OBSCN | | | | 0 | 0 |
NYAP2 | | | | 0 | 0 |
NUTM2A | | | | 0 | 0 |
NUTM1 | | | | 0 | 0 |
NUP98 | 急性髓性白血病 | | | 1 | 1 |